| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ilijas Jelcic, James V M Hanson, Sebastian Lukas, Konrad P Weber, Klara Landau, Misha Pless, Markus Reindl, Michael Weller, Roland Martin, Andreas Lutterotti, Sven Schipplin. Unfavorable Structural and Functional Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. vol 39. issue 1. 2020-06-15. PMID:30015656. |
recurrent optic neuritis (ron) associated with myelin oligodendrocyte glycoprotein (mog)-specific antibodies has been initially reported to show a better clinical outcome than aquaporin-4 (aqp4)-seropositive on in neuromyelitis optica spectrum disorder (nmosd). |
2020-06-15 |
2023-08-13 |
Not clear |
| Ünsal Yılmaz, Selvinaz Edizer, Çisel Yazan Songür, Yiğithan Güzin, Fatma Sibel Dura. Atypical presentation of MOG-related disease: Slowly progressive behavioral and personality changes following a seizure. Multiple sclerosis and related disorders. vol 36. 2020-06-08. PMID:31525625. |
myelin oligodendrocyte glycoprotein (mog) antibodies-related disease is mainly presented with acute disseminated encephalomyelitis (adem), recurrent optic neuritis, and neuromyelitis optica spectrum disorders (nmosds), however the complete clinical spectrum has not yet been defined. |
2020-06-08 |
2023-08-13 |
Not clear |
| Ling Fang, Xinmei Kang, Zhen Wang, Shisi Wang, Jingqi Wang, Yifan Zhou, Chen Chen, Xiaobo Sun, Yaping Yan, Allan G Kermode, Lisheng Peng, Wei Qi. Myelin Oligodendrocyte Glycoprotein-IgG Contributes to Oligodendrocytopathy in the Presence of Complement, Distinct from Astrocytopathy Induced by AQP4-IgG. Neuroscience bulletin. vol 35. issue 5. 2020-03-03. PMID:31041694. |
immunoglobulin g against myelin oligodendrocyte glycoprotein (mog-igg) is detectable in neuromyelitis optica spectrum disorder (nmosd) without aquaporin-4 igg (aqp4-igg), but its pathogenicity remains unclear. |
2020-03-03 |
2023-08-13 |
mouse |
| Silke Häusser-Kinzel, Martin S Webe. The Role of B Cells and Antibodies in Multiple Sclerosis, Neuromyelitis Optica, and Related Disorders. Frontiers in immunology. vol 10. 2020-02-25. PMID:30800132. |
the first one is neuromyelitis optica in which an antibody response against aquaporin-4 targets and destroys astrocytes, the second, likely distinct entity embraces a group of patients containing antibodies against myelin oligodendrocyte glycoprotein. |
2020-02-25 |
2023-08-13 |
Not clear |
| A Bellinvia, L Pastò, L Razzolini, R Fratangelo, E Prestipino, M Fonderico, L Tudisco, M P Amat. The clinical spectrum of anti-MOG associated acquired demyelinating disorders: Three case-reports. Multiple sclerosis and related disorders. vol 33. 2020-01-13. PMID:31152967. |
there is now growing evidence that supports anti-myelin oligodendrocyte antibodies associated demyelination as a distinct disease entity, with some clinical characteristics that somehow overlap those of multiple sclerosis (ms) and anti-aqp4+ neuromyelitis optica spectrum disorders (aqp4+nmosd) but different pathogenesis and treatment strategies. |
2020-01-13 |
2023-08-13 |
Not clear |
| Magnus S Boesen, Poul E H Jensen, Alfred P Born, Melinda Magyari, Anna C Nilsson, Christina Hoei-Hansen, Morten Blinkenberg, Finn Sellebjer. Incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in Denmark 2008‒2018: A nationwide, population-based cohort study. Multiple sclerosis and related disorders. vol 33. 2020-01-13. PMID:31276927. |
incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in denmark 2008‒2018: a nationwide, population-based cohort study. |
2020-01-13 |
2023-08-13 |
Not clear |
| Magnus S Boesen, Poul E H Jensen, Alfred P Born, Melinda Magyari, Anna C Nilsson, Christina Hoei-Hansen, Morten Blinkenberg, Finn Sellebjer. Incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in Denmark 2008‒2018: A nationwide, population-based cohort study. Multiple sclerosis and related disorders. vol 33. 2020-01-13. PMID:31276927. |
the incidence of pediatric neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein (mog) antibody-associated disease have not been reported previously. |
2020-01-13 |
2023-08-13 |
Not clear |
| Jae-Won Hyun, So-Young Huh, Hyun-June Shin, Mark Woodhall, Su-Hyun Kim, Sarosh R Irani, Sang Hyun Lee, Patrick Waters, Ho Jin Ki. Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis. Multiple sclerosis (Houndmills, Basingstoke, England). vol 25. issue 4. 2020-01-09. PMID:29512413. |
we aimed to evaluate the utility of the recently described brain lesion distribution criteria to differentiate multiple sclerosis (ms) from aquaporin-4 immunoglobulin g-positive neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein immunoglobulin g-associated encephalomyelitis (mog-em) at disease onset in an asian cohort. |
2020-01-09 |
2023-08-13 |
Not clear |
| Edward Margoli. The swollen optic nerve: an approach to diagnosis and management. Practical neurology. vol 19. issue 4. 2020-01-03. PMID:31196885. |
however, if their visual function is affected, the most likely causes are bilateral demyelinating optic neuritis, neuromyelitis optica spectrum disorder and anti-myelin oligodendrocyte glycoprotein optic neuritis: these patients require investigating with contrast-enhanced mri of the orbits. |
2020-01-03 |
2023-08-13 |
Not clear |
| Marilou Caron-Cantin, Dean M Cestari, Elizabeth Forti. Clinical and radiologic approach to 'typical' versus antibody-related optic neuritis. Current opinion in ophthalmology. vol 30. issue 6. 2019-12-20. PMID:31503075. |
optic neuritis is an autoimmune optic neuropathy that has been associated with multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), and more recently antimyelin oligodendrocyte glycoprotein (anti-mog)-positive disorder. |
2019-12-20 |
2023-08-13 |
Not clear |
| Ariana Kamawal, Susanne Hoerning, Matthias Galiano, Oliver Rompel, Regina Trollman. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Neuromyelitis Optica Spectrum Disorder in a 6-Year-Old Boy. Klinische Padiatrie. vol 231. issue 4. 2019-11-18. PMID:31064015. |
myelin oligodendrocyte glycoprotein antibody-associated neuromyelitis optica spectrum disorder in a 6-year-old boy. |
2019-11-18 |
2023-08-13 |
Not clear |
| Shahd H M Hamid, Dan Whittam, Mariyam Saviour, Amal Alorainy, Kerry Mutch, Samantha Linaker, Tom Solomon, Maneesh Bhojak, Mark Woodhall, Patrick Waters, Richard Appleton, Martin Duddy, Anu Jaco. Seizures and Encephalitis in Myelin Oligodendrocyte Glycoprotein IgG Disease vs Aquaporin 4 IgG Disease. JAMA neurology. vol 75. issue 1. 2019-09-05. PMID:29131884. |
antibodies to myelin oligodendrocyte glycoprotein igg (mog-igg) are increasingly detected in patients with non-multiple sclerosis-related demyelination, some of whom manifest a neuromyelitis optica (nmo) phenotype. |
2019-09-05 |
2023-08-13 |
Not clear |
| Jerome de Sez. Myelin oligodendrocyte glycoprotein antibodies in neuromyelitis optica spectrum disorder. Current opinion in neurology. vol 32. issue 1. 2019-08-12. PMID:30562266. |
myelin oligodendrocyte glycoprotein antibodies in neuromyelitis optica spectrum disorder. |
2019-08-12 |
2023-08-13 |
Not clear |
| Sara Salama, Santiago Pardo, Michael Lev. Clinical characteristics of myelin oligodendrocyte glycoprotein antibody neuromyelitis optica spectrum disorder. Multiple sclerosis and related disorders. vol 30. 2019-08-09. PMID:30825703. |
clinical characteristics of myelin oligodendrocyte glycoprotein antibody neuromyelitis optica spectrum disorder. |
2019-08-09 |
2023-08-13 |
Not clear |
| Azusa Ikeda, Yoshihiro Watanabe, Hikari Kaba, Kimihiko Kaneko, Toshiyuki Takahashi, Saoko Takeshit. MRI findings in pediatric neuromyelitis optica spectrum disorder with MOG antibody: Four cases and review of the literature. Brain & development. vol 41. issue 4. 2019-06-17. PMID:30447856. |
myelin oligodendrocyte glycoprotein antibodies (mog abs) are frequently detected in pediatric acquired demyelinating syndrome (ads), and mog-ab-positive ads differs from multiple sclerosis (ms) and aquaporin-4 (aqp4)-ab-positive neuromyelitis optica spectrum disorder (nmosd) in terms of age distribution, therapeutic response, and prognosis. |
2019-06-17 |
2023-08-13 |
Not clear |
| Esra Sarigecili, Meltem Direk Cobanogullari, Mustafa Komur, Cetin Okuya. A rare concurrence: Antibodies against Myelin Oligodendrocyte Glycoprotein and N-methyl-d-aspartate receptor in a child. Multiple sclerosis and related disorders. vol 28. 2019-06-12. PMID:30590238. |
especially, patients of acute disseminated encephalomyelitis (adem), multiple sclerosis (ms), aquaporin-4 (aqp4) seronegative neuromyelitis optica spectrum disorder (nmosd), monophasic or recurrent optic neuritis (on), transverse myelitis and n-methyl-d-aspartate (nmda) receptor encephalitis (nmdare) can overlap with myelin oligodendrocyte glycoprotein antibodies. |
2019-06-12 |
2023-08-13 |
Not clear |
| Yuan Yao, Yan Xu, Haitao Ren, Xiangqin Zhou, Liri Jin, Yan Huang, Qiang Lu, Xunzhe Yang, Yao Zhang, Yicheng Zhu, Bin Peng, Liying Cu. Acute epileptic seizures in myelin oligodendrocyte glycoprotein encephalomyelitis and neuromyelitis optica spectrum disorder: A comparative cohort study. Multiple sclerosis and related disorders. vol 27. 2019-04-04. PMID:30448468. |
acute epileptic seizures in myelin oligodendrocyte glycoprotein encephalomyelitis and neuromyelitis optica spectrum disorder: a comparative cohort study. |
2019-04-04 |
2023-08-13 |
Not clear |
| Yuan Yao, Yan Xu, Haitao Ren, Xiangqin Zhou, Liri Jin, Yan Huang, Qiang Lu, Xunzhe Yang, Yao Zhang, Yicheng Zhu, Bin Peng, Liying Cu. Acute epileptic seizures in myelin oligodendrocyte glycoprotein encephalomyelitis and neuromyelitis optica spectrum disorder: A comparative cohort study. Multiple sclerosis and related disorders. vol 27. 2019-04-04. PMID:30448468. |
little is known about the incidence and characteristics of acute epileptic seizures in myelin oligodendrocyte glycoprotein encephalomyelitis (mog-em) and neuromyelitis optica spectrum disorder (nmosd). |
2019-04-04 |
2023-08-13 |
Not clear |
| Monika Bradl, Markus Reindl, Hans Lassman. Mechanisms for lesion localization in neuromyelitis optica spectrum disorders. Current opinion in neurology. vol 31. issue 3. 2019-03-05. PMID:29465432. |
neuromyelitis optica spectrum disorders (nmosd) are severe inflammatory diseases of the central nervous system (cns), with the presence of aquaporin 4 (aqp4)-specific serum antibodies in the vast majority of patients, and with the presence of myelin oligodendrocyte glycoprotein (mog)-specific antibodies in approximately 40% of all aqp4-antibody negative nmosd patients. |
2019-03-05 |
2023-08-13 |
Not clear |
| Emilie Lommers, Frédérique Depierreux, Isabelle Hansen, Dominique Dive, Pierre Maque. NMOSD with anti-MOG antibodies following anti-TNFα therapy: A case report. Multiple sclerosis and related disorders. vol 26. 2019-02-28. PMID:30219743. |
we report and discuss a case of neuromyelitis optica spectrum disorder (nmosd) with positive myelin oligodendrocyte glycoprotein antibodies (mog-igg1) following anti-tnfα therapy for a pustular psoriasis. |
2019-02-28 |
2023-08-13 |
Not clear |